Glaxosmithkline Plc (NY: GSK )
38.36
USD
+0.58
(+1.54%)
Official Closing Price
Updated: 7:56 PM EST, Jan 22, 2021
Add to My Watchlist
Stories about Glaxosmithkline Plc
‘We can’t let our guard down’: Scientists say some children simultaneously tested positive for COVID-19 antibodies and coronavirus
September 03, 2020
From MarketWatch
Coronavirus update: Global tally climbs above 26 million, U.S. above 6.1 million amid concerns CDC will rush out a vaccine
September 03, 2020
From MarketWatch
The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax
September 03, 2020
From Benzinga
Pfizer Rises On Coronavirus Vaccine Supply Deals — But Is PFE Stock A Buy?
September 03, 2020
From Benzinga
Sanofi, GSK Start Early-Stage Clinical Trials Of Jointly-Developed COVID-19 Vaccine
September 03, 2020
From Benzinga
‘My brother was my best friend’: He moved into my late father’s home, changed the locks and blew through his money. Should I pursue criminal charges?
September 03, 2020
From MarketWatch
From Benzinga
As students return to school, are face shields really effective against COVID-19?
September 02, 2020
From MarketWatch
My father left me money for a house — and my husband put his name on the deed. How do I ensure it goes to our kids?
September 02, 2020
From MarketWatch
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
September 01, 2020
From Benzinga
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent
September 01, 2020
From Benzinga
‘I tried walking more than 3 blocks, paying the price with chest pains and crippling fatigue’: One woman’s long-haul recovery from COVID-19
September 01, 2020
From MarketWatch
‘Their first instinct was to face the crisis by buying a gun’: Charlotte deals with life after the GOP Convention amid COVID-19 — and braces for November’s election
September 01, 2020
From MarketWatch
From Benzinga
The treatment to prevent hospitalization from COVID-19 could be available in the first half of 2021.
From Motley Fool
COVID-19 Update: Gottlieb On Vaccine Approval Timeline, GSK Exec Talks Antibody Drug
August 31, 2020
From Benzinga
Coronavirus update: U.S. case tally edges closer to 6 million and FDA head says he won’t be pressured to rush out a vaccine
August 31, 2020
From MarketWatch
A Divergence Has Occurred In Healthcare
August 31, 2020
From Benzinga
My husband’s RV is his pride and joy — but he owes $75,000 on it. If he dies, am I liable for this debt?
August 31, 2020
From MarketWatch
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
August 30, 2020
From Blogs - TalkMarkets
Has The COVID-19 Vaccine Stock Bubble Burst?
August 30, 2020
From Motley Fool
As COVID-19 cases hit 25 million, Dr. Fauci says it’s ‘conceivable’ we’ll know if there’s a safe vaccine by November
August 30, 2020
From MarketWatch
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
August 30, 2020
From Benzinga
Friday Market Review - Friday, August 28
August 28, 2020
From Blogs - TalkMarkets
3 Stocks to Buy Ahead of the Next Market Crash
August 27, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.